Prediction of intestinal absorption: comparative assessment of gastroplus™ and idea

We have assessed two commercial software tools employing physiologically based models for prediction of intestinal absorption in human. idea™ 2.0 and gastroplus™ 3.1.0 were compared both in their ability to predict fraction absorbed for a set of 28 drugs and in terms of the functionality offered. Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutical sciences 2002-10, Vol.17 (1), p.51-61
Hauptverfasser: Parrott, Neil, Lavé, Thierry
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We have assessed two commercial software tools employing physiologically based models for prediction of intestinal absorption in human. idea™ 2.0 and gastroplus™ 3.1.0 were compared both in their ability to predict fraction absorbed for a set of 28 drugs and in terms of the functionality offered. The emphasis was placed on the practical usefulness to pharmaceutical drug discovery. Predictions were assessed for three levels of input data (i) pure in silico input, (ii) thermodynamic solubility and in silico permeability, (iii) thermodynamic solubility and human colon carcinoma cell line (CACO-2) permeability. We found the pure in silico prediction ability of the tools to be comparable with 70% correct classification rate. With measured input data the idea™ prediction rate improved to 79% while gastroplus™ stayed at 70%. In terms of functionality gastroplus™ is a powerful system for the trained user. Open access to model parameters, diagnostic tools and the ability to integrate data make it particularly suitable for the later stages of discovery and development. idea™ is web based and presents a simple interface suitable for widespread use with minimal training. However the limited functionality and inconvenient handling of multiple compound batches currently restrict the usefulness of version 2.0 for drug discovery.
ISSN:0928-0987
1879-0720
DOI:10.1016/S0928-0987(02)00132-X